3
Participants
Start Date
January 31, 2014
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
Pomalidomide
"Phase I: Starting dose of Pomalidomide 1 mg/day by mouth on days 1-21 of a 28 day cycle.~Phase II: Starting dose of Pomalidomide maximum tolerated dose from Phase I."
Melphalan
Phase I and II: 9 mg/m2 by mouth on days 1-4 of a 28-day cycle.
Dexamethasone
Phase I and II: 40 mg/day by mouth on days 1-4 of a 28 day cycle.
Questionnaires
Questionnaires about the feeling in hands and quality of life completed at different time points during the study.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Celgene
INDUSTRY
M.D. Anderson Cancer Center
OTHER